Nagata N, et al. – Taking into account a large series of patients and an important follow–up period, researchers demonstrated that pancreatic cancer (PC) risk and mortality for intraductal papillary mucinous neoplasms (IPMNs) not showing significant change for 5 years is likely to be low, and the non–endoscopic ultrasound–guided fine needle aspiration indication can provide reasonable decisions. Nevertheless, three patients without worsening high–risk features for 5 years developed PC. Importantly, the stop surveillance strategy should be reconsidered.